National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

CNGRC peptide-TNF alpha conjugate
A cytokine-peptide conjugate composed of the cytokine tumor necrosis factor alpha (TNF-alpha) chemically linked to the peptide CNGRC. The peptide moiety CNGRC, a ligand for the membrane-bound metalloprotease CD13, binds to endothelial cells of the angiogenic vasculature that express CD13 (also known as aminopeptidase N); subsequently, the TNF-alpha moiety induces apoptosis in endothelial cells expressing CD13, thereby inhibiting tumor-associated angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CNGRC peptide-tumor necrosis factor alpha conjugate
tumor vasculature-targeted tumor necrosis factor alpha
Abbreviations:NGR-hTNF
NGR-TNF



Previous:clotrimazole, CMF regimen, CMV N495 peptide, CMV pp65 peptide, CMVpp65-A*0201 peptide vaccine
Next:Co-Rax, Cocculus/nux vomica/tabacum/petroleum extract, codeine phosphate, coenzyme Q10, CoFactor

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov